Paper39759554
Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.
Najjar F and 7 others. Rep Pract Oncol Radiother, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer. Papers, record 39759554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39759554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28456778 | Increased number of endothelial progenitors in peripheral blood as a possible early marker of tumour growth in post-menopausal breast cancer patients. | J Physiol Pharmacol | 2017 | https://conductscience.org/library/papers/28456778 | PubMed |
| 2 | 12654259 | Angiogenesis and apoptosis. | Semin Cancer Biol | 2003 | https://conductscience.org/library/papers/12654259 | PubMed |
| 3 | 37456701 | Locally advanced non-small cell lung cancer: current issues and recent trends. | Rep Pract Oncol Radiother | 2023 | https://conductscience.org/library/papers/37456701 | PubMed |
| 4 | 23882070 | Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival. | Eur J Cardiothorac Surg | 2013 | https://conductscience.org/library/papers/23882070 | PubMed |
| 5 | 16550195 | The hematopoietic stem cell in its place. | Nat Immunol | 2006 | https://conductscience.org/library/papers/16550195 | PubMed |
| 6 | 21927909 | Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer. | J Cancer Res Clin Oncol | 2011 | https://conductscience.org/library/papers/21927909 | PubMed |
| 7 | 16849585 | Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. | Cancer Res | 2006 | https://conductscience.org/library/papers/16849585 | PubMed |
| 8 | 29391882 | Roles of circulating endothelial progenitor cells and endothelial cells in gastric carcinoma. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29391882 | PubMed |
| 9 | 22198428 | Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. | J Thorac Oncol | 2012 | https://conductscience.org/library/papers/22198428 | PubMed |
| 10 | 29872695 | The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients. | NPJ Precis Oncol | 2017 | https://conductscience.org/library/papers/29872695 | PubMed |
| 11 | 12837583 | Endothelial progenitor cells: isolation and characterization. | Trends Cardiovasc Med | 2003 | https://conductscience.org/library/papers/12837583 | PubMed |
| 12 | 22160642 | Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22160642 | PubMed |
| 13 | 28982871 | Association Between Endothelial Progenitor Cells and Treatment Response in Non-Squamous Non-small Cell Lung Cancer Treated with Bevacizumab. | Anticancer Res | 2017 | https://conductscience.org/library/papers/28982871 | PubMed |
| 14 | 18443294 | Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18443294 | PubMed |
| 15 | 19097774 | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19097774 | PubMed |
| 16 | 20732306 | Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. | Biochem Biophys Res Commun | 2010 | https://conductscience.org/library/papers/20732306 | PubMed |
| 17 | 26917455 | Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis. | Crit Rev Oncol Hematol | 2016 | https://conductscience.org/library/papers/26917455 | PubMed |
| 18 | 14528288 | Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents. | Oncogene | 2003 | https://conductscience.org/library/papers/14528288 | PubMed |
| 19 | 16549839 | Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16549839 | PubMed |
| 20 | 31731627 | Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence. | J Clin Med | 2019 | https://conductscience.org/library/papers/31731627 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42015273 | The predictive value and clinical application of measuring circulating endothelial progenitor cells in lung adenocarcinoma. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42015273 | PubMed |
| 41498077 | The evaluation of serum magnesium and calcium/magnesium ratio in patients with breast cancer receiving adjuvant chemotherapy. | Rep Pract Oncol Radiother | 2025 | https://conductscience.org/library/papers/41498077 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| MCAM | 4162 | PubTator's text mining | https://conductscience.org/library/genes/4162 | NCBI Gene |
| PROM1 | 8842 | PubTator's text mining | https://conductscience.org/library/genes/8842 | NCBI Gene |
| PTPRC | 5788 | PubTator's text mining | https://conductscience.org/library/genes/5788 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39759554
GET https://conductscience.org/api/papers/v1/39759554/references?page=2